Processing

Please wait...

Settings

Settings

Goto Application

1. WO2013016634 - USE OF IL-12 TO GENERATE ENDOGENOUS ERYTHROPOIETIN

Publication Number WO/2013/016634
Publication Date 31.01.2013
International Application No. PCT/US2012/048540
International Filing Date 27.07.2012
IPC
A61K 39/395 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
CPC
A61K 38/208
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
19Cytokines; Lymphokines; Interferons
20Interleukins [IL]
208IL-12
A61P 25/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
A61P 7/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
06Antianaemics
C07K 14/55
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
52Cytokines; Lymphokines; Interferons
54Interleukins [IL]
55IL-2
Applicants
  • NEUMEDICINES, INC. [US]/[US] (AllExceptUS)
  • BASILE, Lena, A. [US]/[US] (UsOnly)
Inventors
  • BASILE, Lena, A.
Agents
  • SIMKIN, Michele, M.
Priority Data
61/512,34427.07.2011US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF IL-12 TO GENERATE ENDOGENOUS ERYTHROPOIETIN
(FR) UTILISATION D'IL-12 POUR GÉNÉRER DE L'ÉRYTHROPOÏÉTINE ENDOGÈNE
Abstract
(EN)
The present invention relates to the use of exogenous interleukin-12 (IL-12) for increasing endogenous production of erythropoietin.
(FR)
La présente invention concerne l'utilisation d'interleukine-12 (IL-12) exogène pour augmenter la production endogène d'érythropoïétine.
Latest bibliographic data on file with the International Bureau